Werness B A, Levine A J, Howley P M
Laboratory of Tumor Virus Biology, National Cancer Institute, Bethesda, MD 20892.
Science. 1990 Apr 6;248(4951):76-9. doi: 10.1126/science.2157286.
Human papillomavirus type 16 (HPV-16) is a DNA tumor virus that is associated with human anogenital cancers and encodes two transforming proteins, E6 and E7. The E7 protein has been shown to bind to the retinoblastoma tumor suppressor gene product, pRB. This study shows that the E6 protein of HPV-16 is capable of binding to the cellular p53 protein. The ability of the E6 proteins from different human papillomaviruses to form complexes with p53 was assayed and found to correlate with the in vivo clinical behavior and the in vitro transforming activity of these different papillomaviruses. The wild-type p53 protein has tumor suppressor properties and has also been found in association with large T antigen and the E1B 55-kilodalton protein in cells transformed by SV40 and by adenovirus type 5, respectively, providing further evidence that the human papillomaviruses, the adenoviruses, and SV40 may effect similar cellular pathways in transformation.
16型人乳头瘤病毒(HPV - 16)是一种DNA肿瘤病毒,与人类肛门生殖器癌症相关,并编码两种转化蛋白E6和E7。已表明E7蛋白可与视网膜母细胞瘤肿瘤抑制基因产物pRB结合。本研究表明,HPV - 16的E6蛋白能够与细胞p53蛋白结合。检测了来自不同人乳头瘤病毒的E6蛋白与p53形成复合物的能力,发现其与这些不同乳头瘤病毒的体内临床行为和体外转化活性相关。野生型p53蛋白具有肿瘤抑制特性,并且分别在由SV40和5型腺病毒转化的细胞中与大T抗原和E1B 55千道尔顿蛋白相关联,这进一步证明人乳头瘤病毒、腺病毒和SV40在转化过程中可能影响相似的细胞途径。